1. Ishida N, Saito M. Sequential appearance of effector cells and cytokines in tumor-bearing mice given five consecutive intraperitoneal injection of OK-432, a killed streptococcal preparation. Biotherapy 1990; 4: 155–165.
2. Tokai cooperative study group of adjuvant-immunochemotherapy of the stomach cancer. Study on adjuvant immunochemotherapy of the stomach cancer. Jpn J Cancer Chemother 1976; 3: 715–721.
3. Yagawa H, Ogawa K, Ohtani Y, Kajiwara T, Sakakibara N. Immunochemotherapy for gastric cancer after surgical treatment. OK-432. Tokyo: Excepta Medica, 1984: 290–299.
4. Ogawa K, Yagawa H, Katsube T, Kawada H, Ohtani Y, Sakakibara N. A study on anti-tumor reaction of regional lymph nodes in gastric cancer. Jpn J Gastroenterol Surg 1986; 19: 862–866.
5. Katsube T. Preoperative endoscopic administration of OK-432 into lesions of early gastric cancer. J Jpn Soc Clin Surg 1987; 48: 1600–1610.